A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab ... - AACR Journals

A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.